Maravai LifeSciences Holdings Inc Ordinary Shares - Class A (MRVI)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$2.12
Buy
$2.14
$0.14 (+7.07%)
Prices updated at 13 May 2025, 00:58 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Robert Andrew Eckert
CEO
Mr. William E. Martin, III
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
570
Head office
10770 Wateridge Circle
San Diego
United States
92121
Key personnel
Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
---|---|---|---|---|---|
Mr. Gregory T. Lucier Independent Director | 0.06m | - | - | 0.28m | - |
Dr. John A. DeFord, PhD Independent Director | 0.09m | - | - | 0.31m | - |
Dr. Peter M. Leddy, PhD Chief Administrative Officer | 0.48m | 0.07m | - | 2.36m | - |
Dr. Jessica Hopfield, PhD Independent Director | 0.09m | - | - | 0.31m | - |
Mr. Kevin Herde Chief Financial Officer and Principal Accounting Officer | 0.49m | 0.07m | - | 2.34m | - |
Ms. Christine Dolan Executive Vice President and General Manager, Cygnus Technologies | - | - | - | - | - |
Mr. Sean L. Cunningham Director | 0.07m | - | - | 0.29m | - |
Mr. Constantine S. Mihas Director | 0.07m | - | - | 0.29m | - |
Mr. Kurt Oreshack General Counsel and Secretary | - | - | - | - | - |
Mr. Benjamin Daverman Director | 0.06m | - | - | 0.28m | - |
Ms. Susannah Gray, M.B.A. Independent Director | 0.10m | - | - | 0.32m | - |
Mr. Luke Marker Director | 0.06m | - | - | 0.28m | - |
Dr. Murali K. Prahalad, PhD Independent Director | 0.07m | - | - | 0.29m | - |
Mr. William E. Martin, III Chief Executive Officer and Director | 0.78m | - | - | 6.38m | - |
Ms. Rebecca Buzzeo Executive Vice President and Chief Commercial Officer | 0.47m | 0.05m | - | 2.46m | - |
Mr. Robert Andrew Eckert Chairman of the Board | - | - | - | 0.22m | - |
Top 5 shareholders
Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
---|---|---|---|---|---|---|
GTCR Investment XI LLC | 130,834,085 | - | -9940974 | -7.061602 | 30 Apr 2025 | 92.24 |
GTCR LLC | 20,150,005 | 10.56089 | - | - | 30 Apr 2025 | 14.00 |
Mackenzie Investments | 12,365,432 | 0.04441 | 6002020 | 94.320783 | 30 Apr 2025 | 8.59 |
Vanguard Group Inc | 11,821,424 | 0.00112 | -60316 | -0.507636 | 30 Apr 2025 | 8.21 |
12 West Capital Management LP | 11,591,335 | 6.61775 | -2419844 | -17.270809 | 30 Apr 2025 | 8.05 |
Director dealings
Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
---|---|---|---|---|---|---|---|
09 Dec 2024 | - | Mr. Gregory T. Lucier | - | - | 20,645 | - | - |
09 Dec 2024 | - | Mr. Gregory T. Lucier | - | - | 55,123 | - | - |
15 Nov 2024 | - | Ms. Rebecca Buzzeo | 4.42 | 19,284 | 360,703 | - | - |
12 Nov 2024 | - | Dr. John A. DeFord, PhD | 5.75 | 100,625 | 70,046 | - | - |
11 Nov 2024 | - | Mr. Carl W. Hull | 5.64 | 987,000 | 175,000 | - | - |
31 Oct 2024 | - | Mr. Kevin Herde | 5.70 | 10,864 | 336,600 | - | - |
31 Oct 2024 | - | Ms. Christine Dolan | 5.70 | 10,534 | 260,338 | - | - |
31 Oct 2024 | - | Mr. Kurt Oreshack | 5.70 | 2,086 | 224,056 | - | - |
31 Oct 2024 | - | Mr. Andrew Burch | 5.70 | 10,494 | 423,595 | - | - |
15 Oct 2024 | - | Mr. William Martin, III | 8.29 | 421,488 | 989,430 | - | - |
15 Jul 2024 | - | Dr. Peter M. Leddy, PhD | 8.76 | 45,149 | 375,781 | - | - |
23 May 2024 | - | Mr. Gregory T. Lucier | 10.78 | 222,553 | 75,768 | - | - |
23 May 2024 | - | Dr. John A. DeFord, PhD | 10.78 | 222,553 | 52,546 | - | - |
23 May 2024 | - | Dr. Jessica Hopfield, PhD | 10.78 | 222,553 | 110,768 | - | - |
23 May 2024 | - | Mr. Sean L. Cunningham | 10.78 | 222,553 | 48,916 | - | - |
23 May 2024 | - | Mr. Constantine S. Mihas | 10.78 | 222,553 | 48,916 | - | - |
23 May 2024 | - | Mr. Benjamin Daverman | 10.78 | 222,553 | 48,916 | - | - |
23 May 2024 | - | Ms. Susannah Gray, M.B.A. | 10.78 | 222,553 | 80,768 | - | - |
23 May 2024 | - | Mr. Luke Marker | 10.78 | 222,553 | 48,916 | - | - |
23 May 2024 | - | Dr. Murali K. Prahalad, PhD | 10.78 | 222,553 | 65,468 | - | - |
Please note that past performance is not a reliable indicator of future returns.